Latest filing published 07 Oct 2026 for Arbutus Biopharma Corporation, €56k. Read the official filing
Robert Alan Beardsley appears in our data through filings on Arbutus Biopharma Corporation shares, published by SEDI. The record holds 7 filings, for trades running from 8 June 2026 to 1 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 7 October 2026, reports a transaction of €56k in Arbutus Biopharma Corporation. The median gap between a trade and its publication by SEDI is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations